Evidence map›Paper›PMID 20856220›Full record

ReviewNature immunology2010

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Subhra K Biswas, Alberto Mantovani

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04880720 (Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients), which is not on this map. Cited by 2,078 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,078citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04880720 completednot on this mapstarted 2021, after this paper: background citation

Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients

TypeobservationalSponsorUniversity Hospital, MontpellierRan2021 to 2022Enrolled43ConditionsSARS-Cov-2 Infection, Rheumatoid ArthritisArmsBlood sampling
3 · Its place in the literature

Who cites it

2,078 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Interaction of HIF-1a with various cell death pathways in tumor immune microenvironment (TIME).Apoptosis : an international journal on programmed cell death · 2026
    Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. NLRC5-Deficient Macrophages Promote a Tumor-Permissive Phenotype via AXL- and MERTK-Mediated Efferocytosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  18. Review
  19. Article
  20. Review

2,018 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Subhra K BiswasSingapore Immunology Network, Agency for Science, Technology & Research, Singapore. subhra_biswas@immunol.a-star.edu.sg
Alberto Mantovani

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasticity is a hallmark of cells of the myelomonocytic lineage. In response to innate recognition or signals from lymphocyte subsets, mononuclear phagocytes undergo adaptive responses. Shaping of monocyte-macrophage function is an essential component of resistance to pathogens, tissue damage and repair. The orchestration of myelomonocytic cell function is a key element that links inflammation and cancer and provides a paradigm for macrophage plasticity and function. A better understanding of the molecular basis of myelomonocytic cell plasticity will open new vistas in immunopathology and therapeutic intervention.

Indexed as

AnimalsCytokinesHumansInflammationLymphocyte SubsetsMacrophage ActivationMacrophagesMonocytesNeoplasmsCytokines

Identifiers

PMID20856220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.